{"created":"2023-05-15T16:29:52.717422+00:00","id":797,"links":{},"metadata":{"_buckets":{"deposit":"dc589ef8-638a-4526-aa3e-0d77816f1b9b"},"_deposit":{"created_by":2,"id":"797","owners":[2],"pid":{"revision_id":0,"type":"depid","value":"797"},"status":"published"},"_oai":{"id":"oai:nagasaki-u.repo.nii.ac.jp:00000797","sets":["25:26"]},"author_link":["3661","3666","3653","3669","3658","3667","3657","3655","3654","3660","3672","3662","3665","3668","3671","3663","3664","3656","3670","3659"],"item_2_biblio_info_6":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2020-04-20","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"8","bibliographicPageEnd":"1086","bibliographicPageStart":"1081","bibliographicVolumeNumber":"59","bibliographic_titles":[{"bibliographic_title":"Internal Medicine"}]}]},"item_2_description_4":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"Secondary pulmonary alveolar proteinosis (sPAP) is a complication of myelodysplastic syndrome (MDS). A 60-year-old woman was diagnosed with MDS with excess blasts-1. Fifty-four months after the initial diagnosis, treatment with azacitidine was initiated. Seventy-three months after the diagnosis, a bone marrow examination revealed increased myeloblasts, at which time computed tomography showed diffuse ground-glass opacities and interlobular septal thickening in the bilateral lower lung fields. A lung biopsy revealed the presence of PAP; therefore, the clinical diagnosis of MDS/sPAP was confirmed. Careful attention should be paid to the development of sPAP in MDS patients with pulmonary lesions during azacitidine treatment.","subitem_description_type":"Abstract"}]},"item_2_description_63":{"attribute_name":"引用","attribute_value_mlt":[{"subitem_description":"Internal Medicine, 59(8), pp.1081-1086; 2020","subitem_description_type":"Other"}]},"item_2_publisher_33":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"The Japanese Society of Internal Medicine"}]},"item_2_relation_12":{"attribute_name":"DOI","attribute_value_mlt":[{"subitem_relation_type":"isIdenticalTo","subitem_relation_type_id":{"subitem_relation_type_id_text":"10.2169/internalmedicine.3770-19","subitem_relation_type_select":"DOI"}}]},"item_2_rights_13":{"attribute_name":"権利","attribute_value_mlt":[{"subitem_rights":"c 2020 The Japanese Society of Internal Medicine. The Internal Medicine is an Open Access journal distributed under license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/)."}]},"item_2_source_id_7":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"09182918","subitem_source_identifier_type":"ISSN"}]},"item_2_source_id_8":{"attribute_name":"EISSN","attribute_value_mlt":[{"subitem_source_identifier":"13497235","subitem_source_identifier_type":"ISSN"}]},"item_2_text_62":{"attribute_name":"出版者別言語","attribute_value_mlt":[{"subitem_text_value":"日本内科学会"}]},"item_2_version_type_16":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_970fb48d4fbd8a85","subitem_version_type":"VoR"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"Hashimoto, Miki"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Itonaga, Hidehiro"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Nannya, Yasuhito"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Taniguchi, Hirokazu"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Fukuda, Yuichi"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Furumoto, Takafumi"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Fujioka, Machiko"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Kasai, Sachie"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Taguchi, Masataka"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Taniguchi, Hiroaki"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Sato, Shinya"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Sawayama, Yasushi"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Atogami, Sunao"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Iwasaki, Keisuke"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Hata, Tomoko"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Soda, Hiroshi"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Moriuchi, Yukiyoshi"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Nakata, Koh"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Ogawa, Seishi"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Miyazaki, Yasushi"}],"nameIdentifiers":[{}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2020-12-18"}],"displaytype":"detail","filename":"IntMed59_1081.pdf","filesize":[{"value":"1.9 MB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"IntMed59_1081.pdf","url":"https://nagasaki-u.repo.nii.ac.jp/record/797/files/IntMed59_1081.pdf"},"version_id":"b610664e-e26c-428b-940c-f13a33d0520a"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"myelodysplastic syndromes","subitem_subject_scheme":"Other"},{"subitem_subject":"secondary pulmonary alveolar proteinosis","subitem_subject_scheme":"Other"},{"subitem_subject":"azacitidine","subitem_subject_scheme":"Other"},{"subitem_subject":"umbilical cord blood transplantation","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"Secondary Pulmonary Alveolar Proteinosis Following Treatment with Azacitidine for Myelodysplastic Syndrome","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Secondary Pulmonary Alveolar Proteinosis Following Treatment with Azacitidine for Myelodysplastic Syndrome"}]},"item_type_id":"2","owner":"2","path":["26"],"pubdate":{"attribute_name":"公開日","attribute_value":"2020-05-19"},"publish_date":"2020-05-19","publish_status":"0","recid":"797","relation_version_is_last":true,"title":["Secondary Pulmonary Alveolar Proteinosis Following Treatment with Azacitidine for Myelodysplastic Syndrome"],"weko_creator_id":"2","weko_shared_id":-1},"updated":"2023-05-16T04:13:02.862123+00:00"}